Exercise-induced pulmonary haemorrhage in Thoroughbred racehorses: a longitudinal study

2018 ◽  
Vol 51 (1) ◽  
pp. 45-51 ◽  
Author(s):  
E. J. Crispe ◽  
C. J. Secombe ◽  
D. I. Perera ◽  
A. A. Manderson ◽  
B. A. Turlach ◽  
...  
2021 ◽  
Author(s):  
Bianca Cascardo ◽  
Camila Bernardes ◽  
Guilherme Souza ◽  
Katia Silva ◽  
Natália Pires ◽  
...  

2017 ◽  
Vol 49 (5) ◽  
pp. 584-589 ◽  
Author(s):  
E. J. Crispe ◽  
G. D. Lester ◽  
C. J. Secombe ◽  
D. I. Perera

2014 ◽  
Vol 47 (3) ◽  
pp. 358-365 ◽  
Author(s):  
P. S. Morley ◽  
J. L. Bromberek ◽  
M. N. Saulez ◽  
K. W. Hinchcliff ◽  
A. J. Guthrie

2010 ◽  
Vol 42 ◽  
pp. 228-234 ◽  
Author(s):  
K. W. HINCHCLIFF ◽  
P. S. MORLEY ◽  
M. A. JACKSON ◽  
J. A. BROWN ◽  
A. F. DREDGE ◽  
...  

2018 ◽  
Vol 9 (1) ◽  
pp. 02-03
Author(s):  
Maria Fernanda De Mello Costa ◽  
Juliana N.P. Pereira ◽  
Garry A. Anderson

Racehorses are commonly affected by a condition known as Exercise Induced Pulmonary Haemorrhage (EIPH) which consists of rupture of alveolar membranes and extravasation of blood into the airways. EIPH is considered to negatively affect racehorse performance and there is no current treatment. In order to reduce the amount of bleeding the diuretic furosemide has been used prior to exercise and competition in some racing jurisdictions. Efficacy of furosemide in reducing EIPH is documented in this research through endoscopic observation of the airways of horses positive for EIPH in two consecutive races.


Sign in / Sign up

Export Citation Format

Share Document